Positive serological tests for syphilis and administration of intravenous immunoglobulin
- 1Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
- 2Department of Medical Microbiology and Genito-urinary Medicine, University of Liverpool, Liverpool, UK
- 3The Walton Centre for Neurology and Neurosurgery, Liverpool, UK
- 4Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK
- Correspondence to: S A Constable Department of Pharmacology and Therapeutics, University of Liverpool, Ashton Street Medical School, Ashton Street, Liverpool L69 3GE, UK; s.constable{at}liverpool.ac.uk
- Accepted 29 March 2006
Abstract
We report the case of a man who tested positive for syphilis following the intravenous administration of human normal immunoglobulin as part of the treatment of Guillain-Barré syndrome. The chronology of the testing suggested the passive acquisition of treponemal antibody. This phenomenon is not widely documented in the medical literature, but is a theoretical risk of treatment, and serves as a reminder to be cautious in the interpretation of such serological tests.
- CSF, cerebrospinal fluid
- EIA, enzyme immunoassay
- GBS, Guillain-Barré syndrome
- HNIG, human normal immunoglobulin
- RPR, rapid plasma reagin
- TPHA, Treponema pallidum haemagglutination assay
- VDRL, Venereal Disease Research Laboratory
Footnotes
-
Competing interests: None declared.
-
Consent: the patient concerned has given his consent to publication.
Ethical approval: not required.







